"Le Centre Hospitalier de Bourg-en-Bresse (CHB) est un établissement de Médecine-Chirurgie-Obstétrique qui compte plus de 900 lits et places, plus de 2 419 professionnels répartis au sein de ses 7 pôles d’activités médicales : Médecine, Chirurgie, Cancérologie, Soins Critiques, Mère-Enfant, Transversal & Support et Gériatrie. Chaque année, le CHB gère également près de 300 000 appels entrants au SAMU 01, plus de 137 000 consultations (hors imagerie, CSP, urgences), plus de 47 000 passages aux Urgences, plus de 12 000 patients sont reçus au bloc opératoire. 120 résidents sont accueillis en USLD et 169 en EHPAD. www .ch-bourg-en-bresse.fr LinkedIN : Centre hospitalier de Bourg-en-Bresse"

During the past decade, CH Bourg en Bresse conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 9 clinical trials were completed, i.e. on average, 19.1% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 4 clinical trials were completed. i.e. 19% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Bourg en Bresse" #1 sponsor was "UNICANCER" with 9 trials, followed by "The Lymphoma Academic Research Organisation" with 8 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 6 trials sponsored, "ARCAGY/ GINECO GROUP" with 5 trials sponsored and "Hospices Civils de Lyon" with 5 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Bourg en Bresse" #1 collaborator was "UNICANCER" with 3 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator, "Hospices Civils de Lyon" with 2 trials as a collaborator and "Lymphoma Study Association" with 2 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "CH Bourg en Bresse" are "Breast Cancer" (6 trials), "Colorectal Cancer" (5 trials), "Multiple Myeloma" (5 trials), "Metastatic Breast Cancer" (4 trials) and "Carcinoma, Non-Small-Cell Lung" (3 trials). Many other conditions were trialed in "CH Bourg en Bresse" in a lesser frequency.

Most popular intervention types in "CH Bourg en Bresse" are "Drug" (50 trials), "Procedure" (13 trials), "Other" (12 trials), "Biological" (6 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (11 trials), "Placebo" (5 trials), "cyclophosphamide" (5 trials), "epirubicin hydrochloride" (5 trials) and "leucovorin calcium" (5 trials). Other intervention names were less common.

The vast majority of trials in "CH Bourg en Bresse" are 67 trials for "All" genders and 15 trials for "Female" genders.

Currently, there are NaN active trials in "CH Bourg en Bresse". undefined are not yet recruiting, 14 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in CH Bourg en Bresse, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in CH Bourg en Bresse, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".

CH Bourg en Bresse has several departments that took part in Clinical trials: "Centre Hospitalier Fleyriat; Oncologie/Hematologie" - 9 trials, "Office-based Specialist in vascular medecine" - 2 trials, "Ch De Fleyriat; Pneumologie 1" - 2 trials, "Ch De Fleyriat; Gastro Enterologie" - 2 trials